Centre Oscar Lambret - Lille

Lille 59020

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Transitional Cell, Neoplasms, Urothelial Carcinoma

Studies at this site

• Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma — Completed
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed
• Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors — Completed